https://www.selleckchem.com/pr....oducts/evobrutinib.h
eas for the p16+ patients, positive nodes were only observed in level II (p=0.03). This study demonstrated the higher prevalence of cN+ and pN+ in p16+ OP-SCC patients, but without meaningful difference in the distribution of the lymph node drainage between p16- and p16+ OP-SCC. It indicates that no difference should be made between p16- and p16+ patients regarding the extend of neck treatment. This study demonstrated the higher prevalence of cN+ and pN+ in p16+ OP-SCC patients, but without meaningful difference in the distribution
Like
Comment
Share
